GlassScriptPhysician profile
Daniel Nucete
NPI 1043883598
$2,184.78
in general payments reported to CMS, 2019-2025
15 companies · $1,351 in 2025
The $1,351 reported for 2025 was more than what 85% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $136 · 2023: $136 · 2024: $562 · 2025: $1,351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,330 · Travel and Lodging: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.40 |
| Travel and Lodging | $718.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,147.88 | 2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Inari Medical, INC. | $342.49 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $124.45 | 2024 | |
| Kestra Medical Technology Services, INC. | $119.97 | 2025 | Assure Wcd |
| Bolton Medical INC | $83.71 | 2023-2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Silk Road Medical, INC. | $73.54 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $52.70 | 2022-2025 | General - Therapies |
| Cook Medical LLC | $41.94 | 2022 | |
| Endologix LLC | $40.72 | 2023 | Afx2 Bifurcated Endograft System |
| Janssen Pharmaceuticals, INC | $39.00 | 2022 | |
| Abiomed | $33.29 | 2025 | |
| Philips North America LLC | $31.58 | 2024 | (Az7) Lasers |
| Mozarc Medical US LLC | $20.63 | 2024 | Chameleon |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.76 | 2025 | Lifevest |
| Angiodynamics, INC. | $14.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Nucete listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.